Hoolest Performance Technologies, a startup focused on neuro technologies designed to enhance mental health and human performance, announced that its newest technology has reached a new milestone with the launch of a clinical trial seeking FDA approval.
We are investigating the safety and effectiveness of the P57 ONE, an investigational non-invasive neuromodulation device for fast-acting moderate to severe anxiety relief.
Actively recruiting as of October 4, 2021.
Estimated enrollment deadline: December 31, 2021
Anxiety comes from a range of stressors that vary from person to person and can affect your ability to get through the day.Arizona State University alumnus Nick Hool wants to help — and so far has helped people in the Phoenix area using a drug-free, anxiety-relief investigational device developed by his neuroscience-research-based startup, Hoolest Performance Technologies.
What if you could calm your nerves for a better night sleep all without taking any medication?That's the big idea one Arizona State University Ph.D. student is working on.
Hoolest Performance Technologies was the grand winner in Friday's Arizona State University Innovation Open, winning $100,000 from main sponsor Avnet. The Tempe-based student startup targets the 230 million people suffering from performance anxiety, including 6 million who are competitive athletes.
Hoolest Performance Technologies, made up of three ASU engineering students, won the grand prize at the entrepreneurial competition, beating out four other student-led ventures. The $100,000 investment will go toward creating more of the earbud devices, which block stress by stimulating the vagus nerve.
